国药现代
(600420)
| 流通市值：120.21亿 | | | 总市值：134.79亿 |
| 流通股本：11.96亿 | | | 总股本：13.41亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 12,069,930,213.38 | 9,161,881,346.47 | 6,444,526,273.17 | 3,417,169,160.61 |
| 营业收入 | 12,069,930,213.38 | 9,161,881,346.47 | 6,444,526,273.17 | 3,417,169,160.61 |
| 二、营业总成本 | 10,999,674,408.49 | 8,245,179,979.15 | 5,801,514,728.87 | 3,077,218,082.04 |
| 营业成本 | 7,444,013,143.5 | 5,599,739,702.84 | 3,920,100,130.18 | 2,032,906,063.36 |
| 税金及附加 | 138,119,869.62 | 95,646,644.27 | 65,278,104.8 | 29,056,782.15 |
| 销售费用 | 2,153,535,875.44 | 1,671,740,983.16 | 1,252,417,199.34 | 715,994,328.19 |
| 管理费用 | 770,065,790.3 | 552,879,344.52 | 359,968,480.85 | 171,459,977.24 |
| 研发费用 | 569,431,845.96 | 376,892,378.03 | 243,582,857.72 | 110,631,302.54 |
| 财务费用 | -75,492,116.33 | -51,719,073.67 | -39,832,044.02 | 17,169,628.56 |
| 其中:利息费用 | 57,883,690.44 | 48,061,182.85 | 37,752,851.78 | 17,649,699.77 |
| 其中:利息收入 | 109,024,761.94 | 73,599,347.04 | 49,068,807.2 | 16,577,259.26 |
| 加:公允价值变动收益 | - | - | -3,852,000 | - |
| 加:投资收益 | 27,453,725.69 | 13,473,627.27 | -8,009,983.45 | -1,465,257.04 |
| 资产处置收益 | -31,845,024.31 | -1,203,055.34 | -1,004,299.58 | -93,092.76 |
| 资产减值损失(新) | -79,105,481.47 | -51,244,590.13 | -28,295,421.7 | -13,743,121.25 |
| 信用减值损失(新) | 18,054,730.86 | -3,593,379.79 | -16,566,724.05 | -12,752,589.43 |
| 其他收益 | 76,813,337.26 | 39,016,887.4 | 19,642,297.26 | 10,397,780.43 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,081,627,092.92 | 913,150,856.73 | 604,925,412.78 | 322,294,798.52 |
| 加:营业外收入 | 25,490,717.38 | 22,047,431.32 | 18,167,215.21 | 2,901,552.2 |
| 减:营业外支出 | 10,558,245.8 | 9,583,790.58 | 5,533,213.22 | 668,893.27 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,096,559,564.5 | 925,614,497.47 | 617,559,414.77 | 324,527,457.45 |
| 减:所得税费用 | 131,948,830.32 | 128,110,538.27 | 103,038,104.21 | 50,266,056.26 |
| 六、净利润 | 964,610,734.18 | 797,503,959.2 | 514,521,310.56 | 274,261,401.19 |
| 持续经营净利润 | 964,610,734.18 | 797,503,959.2 | 514,521,310.56 | 274,261,401.19 |
| 归属于母公司股东的净利润 | 691,880,495.68 | 563,923,339.31 | 344,942,841.46 | 179,223,645.37 |
| 少数股东损益 | 272,730,238.5 | 233,580,619.89 | 169,578,469.1 | 95,037,755.82 |
| (一)基本每股收益 | 0.54 | 0.45 | 0.29 | 0.15 |
| (二)稀释每股收益 | 0.54 | 0.45 | 0.29 | 0.14 |
| 八、其他综合收益 | 90,798.02 | -74,083.12 | -73,765.4 | -33,464.6 |
| 归属于母公司股东的其他综合收益 | 90,798.02 | -74,083.12 | -73,765.4 | -33,464.6 |
| 九、综合收益总额 | 964,701,532.2 | 797,429,876.08 | 514,447,545.16 | 274,227,936.59 |
| 归属于母公司股东的综合收益总额 | 691,971,293.7 | 563,849,256.19 | 344,869,076.06 | 179,190,180.77 |
| 归属于少数股东的综合收益总额 | 272,730,238.5 | 233,580,619.89 | 169,578,469.1 | 95,037,755.82 |
| 公告日期 | 2024-03-30 | 2023-10-28 | 2023-08-29 | 2023-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |